Literature DB >> 11130769

Association of 5' upstream promoter region of prostacyclin synthase gene variant with cerebral infarction.

T Nakayama1, M Soma, D Rehemudula, Y Takahashi, H Tobe, M Satoh, J Uwabo, M Kunimoto, K Kanmatsuse.   

Abstract

The aim of this study was to investigate whether there is an association between the promoter region of the prostacyclin synthase gene and cerebral infarction (CI). Using the polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) method, we found a variable-number tandem repeat polymorphism in the 5'-upstream promoter region of the prostacyclin synthase gene. This region contains transcriptional factors-binding sites of Spl (CCCGCC) and AP-2 (CCGCCAGCCCC). The alleles varied in size from three to seven repeats of nine base pairs (bp). We performed an association study using the polymorphism in 111 patients and 152 control subjects. The transcriptional activity of the abnormal promoter region allele was determined by luciferase assay. The overall distribution of alleles differed significantly between both groups. Logistic linear regression analysis revealed the small number repeat allele to be found more frequently with CI. Transcriptional activity increased with increasing numbers of repeats. This study provides consistent support for the association between CI and the PGIS gene.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11130769     DOI: 10.1016/s0895-7061(00)01216-4

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  6 in total

1.  Variation in eicosanoid genes, non-fatal myocardial infarction and ischemic stroke.

Authors:  Rozenn N Lemaitre; Kenneth Rice; Kristin Marciante; Joshua C Bis; Thomas S Lumley; Kerri L Wiggins; Nicholas L Smith; Susan R Heckbert; Bruce M Psaty
Journal:  Atherosclerosis       Date:  2008-11-01       Impact factor: 5.162

2.  Haplotype-based case study of human CYP4A11 gene and cerebral infarction in Japanese subject.

Authors:  Zhenyan Fu; Tomohiro Nakayama; Naoyuki Sato; Yoichi Izumi; Yuji Kasamaki; Atsushi Shindo; Masakatsu Ohta; Masayoshi Soma; Noriko Aoi; Mikano Sato; Koichi Matsumoto; Yukio Ozawa; Yitong Ma
Journal:  Endocrine       Date:  2008-05-17       Impact factor: 3.633

3.  Relationship between CYP17A1 genetic polymorphism and coronary artery disease in a Chinese Han population.

Authors:  Chuan-Fang Dai; Xiang Xie; Yi-Ning Yang; Xiao-Mei Li; Ying-Ying Zheng; Zhen-Yan Fu; Fen Liu; Bang-Dang Chen; Min-Tao Gai; Yi-Tong Ma
Journal:  Lipids Health Dis       Date:  2015-03-07       Impact factor: 3.876

Review 4.  Prostaglandin terminal synthases as novel therapeutic targets.

Authors:  Shuntaro Hara
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2017       Impact factor: 3.493

5.  Genetic variants of PTGS2, TXA2R and TXAS1 are associated with carotid plaque vulnerability, platelet activation and TXA2 levels in ischemic stroke patients.

Authors:  Xingyang Yi; Jing Lin; Hua Luo; Chun Wang; Yingying Liu
Journal:  PLoS One       Date:  2017-07-12       Impact factor: 3.240

6.  A novel variable number of tandem repeat of the natriuretic peptide precursor B gene's 5'-flanking region is associated with essential hypertension among Japanese females.

Authors:  Kotoko Kosuge; Masayoshi Soma; Tomohiro Nakayama; Noriko Aoi; Mikano Sato; Yoichi Izumi; Koichi Matsumoto
Journal:  Int J Med Sci       Date:  2007-05-16       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.